Early imaging and circulating marker features of gallbladder carcinoma

doi:10.16352/j.issn.1001-6325.2024.02.0265

Abstract

Abstract: Gallbladder carcinoma (GBC) is one of the most common malignant tumors in the biliary system, which is difficult to diagnose in the early stage due to its high degree of malignancy, invasiveness and lack of specific clinical manifestations. In this paper, we summarize ultrasound, CT and other imaging manifestations in the early stage of GBC, and describe the role of protein markers and microRNA marker as biomarkers in the diagnosis of early GBC. The enhanced understanding of the relevant features might help to improve the accuracy of the diagnosis of early gallbladder carcinoma.

Key words: gallbladder cancer, early diagnosis, imageology, circulating markers

CLC Number:

R735.8

ZHAO Yongzhong, XUE Yi, LI Liqun, HOU Mengsen, YANG Xiaojun. Early imaging and circulating marker features of gallbladder carcinoma[J]. Basic & Clinical Medicine, 2024, 44(2): 265-269.

0
/ / Recommend

Add to citation manager EndNote|Reference Manager|ProCite|BibTeX|RefWorks

URL: http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/10.16352/j.issn.1001-6325.2024.02.0265

http://journal11.magtechjournal.com/Jwk_jcyxylc/EN/Y2024/V44/I2/265

References

[1]Wang X, Lin YK, Lu ZL, et al. Circular RNA circ-MTO1 serves as a novel potential diagnostic and prognostic biomarker for gallbladder cancer [J]. Eur Rev Med Pharmacol Sci, 2020, 24: 8359-8366.doi:10.26355/eurrev_202008_22632.
[2]周迪, 翁明哲, 全志伟. “意外胆囊癌”不规范诊断命名的纠正和预防策略[J]. 中华外科杂志,2020, 58:490-493
[3]Yamaguchi J, Kaneoka Y, Maeda A, et al. Benefit of extended radical surgery for incidental gallbladder carcinoma [J]. Surg Today, 2016, 46: 453-459.doi:10.1007/s00595-015-1198-z.
[4]Zhang HP, Bai M, Gu JY, et al. Value of contrast-enhanced ultrasound in the differential diagnosis of gallbladder lesion [J]. World J Gastroenterol, 2018, 24: 744-751.doi:10.3748/wjg.v24.i6.744.
[5]Kong WT, Shen HY, Qiu YD, et al. Application of contrast enhanced ultrasound in gallbladder lesion: is it helpful to improve the diagnostic capabilities? [J]. Med Ultrason, 2018, 20: 420-426.doi:10.11152/mu-1626.
[6]Chen LD, Huang Y, Xie XH, et al. Diagnostic nomogram for gallbladder wall thickening mimicking malignancy: using contrast-enhanced ultrasonography or multi-detector computed tomography? [J]. Abdom Radiol (NY), 2017, 42: 2436-2446.doi:10.1007/s00261-017-1162-z.
[7]Miwa H, Numata K, Sugimori K, et al. Differential diagnosis of gallbladder polypoid lesions using contrast-enhanced ultrasound [J]. Abdom Radiol (NY), 2019, 44: 1367-1378.doi:10.1007/s00261-018-1833-4.
[8]Serra C, Felicani C, Mazzotta E, et al. CEUS in the differential diagnosis between biliary sludge, benign lesions and malignant lesions [J]. J Ultrasound, 2018, 21: 119-126.doi:10.1007/s40477-018-0286-5.
[9]Jang SI, Kim YJ, Kim EJ, et al. Diagnostic performance of endoscopic ultrasound-artificial intelligence using deep learning analysis of gallbladder polypoid lesions [J]. J Gastroenterol Hepatol, 2021, 36: 3548-3555.doi:10.1111/jgh.15673.
[10]Sugimoto M, Irie H, Takasumi M, et al. A simple method for diagnosing gallbladder malignant tumors with subserosa invasion by endoscopic ultrasonography [J]. BMC Cancer, 2021, 21: 288.doi:10.1186/s12885-021-08017-x.
[11]Kang Y, Chae YS, Kim CH, et al. Hyalinizing cholecystitis and associated carcinoma: a case report [J]. J Pathol Transl Med, 2018, 52: 64-66.doi:10.4132/jptm.2016.11.04.
[12]Yuan HX, Cao JY, Kong WT, et al. Contrast-enhanced ultrasound in diagnosis of gallbladder adenoma [J]. Hepatobiliary Pancreat Dis Int, 2015, 14: 201-207.doi:10.1016/s1499-3872(15)60351-4.
[13]Kim SY, Cho JH, Kim EJ, et al. The efficacy of real-time colour Doppler flow imaging on endoscopic ultrasono-graphy for differential diagnosis between neoplastic and non-neoplastic gallbladder polyps [J]. Eur Radiol, 2018, 28: 1994-2002.doi:10.1007/s00330-017-5175-3.
[14]Han H, Han J. Value of multislice spiral CT in differen-tial diagnosis of thick-wall gallbladder carcinoma and chronic cholecystitis [J]. Contrast Media Mol Imaging, 2022, 2022: 5459779.doi:10.1155/2022/5459779.
[15]Corwin MT, Khera SS, Loehfelm TW, et al. Incidentally detected focal fundal gallbladder wall thickening at contrast-enhanced computed tomography: prevalence and computed tomography features of malignancy [J]. J Comput Assist Tomogr, 2019, 43: 149-154.doi:10.1097/RCT.0000000000000802.
[16]Cha SY, Kim YK, Min JH, et al. Usefulness of noncontrast MRI in differentiation between gallbladder carcinoma and benign conditions manifesting as focal mild wall thickening [J]. Clin Imaging, 2019, 54: 63-70.doi:10.1016/j.clinimag.2018.12.001.
[17]Chu R, Bi W, Tian B, et al. The role of ultrasonography in the diagnosis of gallbladder cancer [J]. Ann Ital Chir, 2021, 92: 372-376.
[18]Liu XF, Zhou LY, Wei ZH, et al. The diagnostic role of circulating inflammation-based biomarker in gallbladder carcinoma [J]. Biomark Med, 2018, 12: 1095-1103.doi:10.2217/bmm-2018-0049.
[19]Vinocha A, Grover RK, Deepak R. Clinical signifi-cance of interleukin-6 in diagnosis of lung, oral, esophageal, and gall bladder carcinomas [J]. J Cancer Res Ther, 2018, 14: S758-S760.doi:10.4103/0973-1482.183217.
[20]Wan Y, Zhang J, Chen M, et al. Elevated serum triglyceride levels may be a key independent predicting factor for gallbladder cancer risk in gallbladder stone disease patients: a case-control study [J]. BMC Endocr Disord, 2022, 22: 270.doi:10.1186/s12902-022-01189-y.
[21]Priya R, Jain V, Akhtar J, et al. Plasma-derived candidate biomarkers for detection of gallbladder carcino-ma [J]. Sci Rep, 2021, 11: 23554.doi:10.1038/s41598-021-02923-7.
[22]Bind MK, Mishra RR, Kumar V, et al. Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder [J]. Indian J Pathol Microbiol, 2021, 64: 65-68.doi:10.4103/IJPM.IJPM_494_19.
[23]Ozer N, Sozutek A, Sahin A, et al. The role of Ca 19-9, Ca 72-4, cea and cholesterol levels in predicting malignancy in gallbladder polyps [J]. J Coll Physicians Surg Pak, 2021, 31: 1422-1427.doi:10.29271/jcpsp.2021.12.1422.
[24]Yang G, Lu Z, Meng F, et al. Circulating miR-141 as a potential biomarker for diagnosis, prognosis and thera-peutic targets in gallbladder cancer [J]. Sci Rep, 2022, 12: 10072.doi:10.1038/s41598-022-13430-8.